Fifth Third Bancorp
OREX

Fifth Third Bancorp’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Fifth Third Bancorp’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-42
Closed -$2K – 2457
2013
Q4 		$2K Hold
42
– – ﹤0.01% 2102
2013
Q3 		$3K Hold
42
– – ﹤0.01% 2110
2013
Q2 		$2K Buy
+42
New +$2.58K ﹤0.01% 2108

Other funds holding OREX

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fifth Third Bancorp's OREX Position: Q1 2014 in Review

Fifth Third Bancorp sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2014, closing a stake of 42 shares — an estimated $2K sold.

Fifth Third Bancorp first reported a position in OREX in Q2 2013 and held it in 3 quarters. The position peaked at $3K in Q3 2013. 129 funds tracked by Wall St. Rank hold OREX as of Q1 2014.

  • Fifth Third Bancorp reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2014 after selling out during the quarter.
  • Fifth Third Bancorp sold 42 Orexigen Therapeutics, Inc. shares in Q1 2014, an estimated $2K.
  • Fifth Third Bancorp first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 3 quarters.
  • Fifth Third Bancorp's Orexigen Therapeutics, Inc. position peaked at $3K in Q3 2013.
  • 129 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2014.

Based on Fifth Third Bancorp's 13F filing for Q1 2014, filed 15 May 2014.